Amicus Therapeutics, Inc. Stock
Stocks
FOLD
US03152W1099
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
23:00:00 24/04/2026 +03
|
5-day change | 1st Jan Change | ||
| 14.49 USD | +0.21% |
|
-.--% | +1.76% |
| 05-05 | BioMarin Enters 'Transition Year' as Enzyme Portfolio Expands After Amicus Deal, Morgan Stanley Says | MT |
| 04-29 | Amicus Therapeutics, Inc.(NasdaqGM:FOLD) dropped from S&P Global BMI Index | CI |
| Market Cap | 4.55B 4.04B 3.77B 3.44B 6.49B 437B 6.55B 45.66B 17.69B 224B 17.08B 16.71B 718B | P/E 2024 |
-51.1x | P/E 2025 | -162x |
|---|---|---|---|---|---|
| Enterprise Value | 4.7B 4.17B 3.9B 3.55B 6.7B 452B 6.76B 47.15B 18.27B 231B 17.64B 17.26B 741B | EV / Sales 2024 |
5.69x | EV / Sales 2025 | 7.18x |
| Free-Float |
99.31% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Amicus Therapeutics, Inc.
| 1 day | +0.21% | ||
| 6 months | +0.35% | ||
| Current year | +1.76% |
| Current year | 14.2 |  | 14.5 |
| 1 year | 7.87 | | 14.5 |
| 3 years | 5.51 | | 14.57 |
| 5 years | 5.51 | | 14.57 |
| 10 years | 4.41 | | 25.39 |
| Manager | Title | Age | Since |
|---|---|---|---|
George Davis
PSD | President | 55 | 27/04/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 4/27/26 A | Issuer sale | General Counsel | 1,264,993 | 0.4029% | ||
| 4/27/26 A | Issuer sale | Director | 395,940 | 0.1261% | ||
| 4/27/26 A | Issuer sale | Chairman | 419,487 | 0.1336% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.21% | -.--% | +75.64% | +31.37% | 4.55B | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.41B | |
| -3.11% | -3.53% | +21.92% | +74.60% | 59.26B | |
| +0.89% | -0.63% | +4.28% | +34.51% | 47.14B | |
| +0.36% | +0.81% | +352.17% | +689.61% | 44.13B | |
| -0.96% | -4.50% | +26.36% | +33.18% | 42.91B | |
| -0.20% | -0.77% | +3.74% | +100.60% | 40.79B | |
| -0.54% | +2.93% | +9.31% | +50.41% | 30.77B | |
| -2.68% | +2.92% | +29.63% | +19.50% | 29.31B | |
| +0.05% | -1.64% | -7.28% | -14.06% | 24.33B | |
| Average | -0.18% | -0.29% | +56.51% | +111.39% | 39.76B | |
| Weighted average by Cap. | +0.10% | -0.72% | +58.65% | +128.11% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 528M 469M 438M 399M 753M 50.79B 760M 5.3B 2.05B 25.96B 1.98B 1.94B 83.32B | 634M 563M 526M 479M 904M 60.97B 913M 6.36B 2.47B 31.17B 2.38B 2.33B 100B |
| Net income | -56.11M -49.85M -46.53M -42.41M -79.98M -5.39B -80.73M -563M -218M -2.76B -211M -206M -8.85B | -27.11M -24.09M -22.48M -20.49M -38.65M -2.61B -39.01M -272M -105M -1.33B -102M -99.58M -4.28B |
| Net Debt | 194M 172M 161M 146M 276M 18.62B 279M 1.94B 753M 9.52B 727M 711M 30.55B | 149M 132M 123M 112M 212M 14.31B 214M 1.49B 579M 7.31B 559M 547M 23.47B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- FOLD Stock
Select your edition
All financial news and data tailored to specific country editions
